NDC 17856-0166-2 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0166
- Requested NDC
- 17856-0166-2
- Package NDCs from labels
- 17856-0166-2, 17856-0166-1, 17856-0166-4, 17856-0166-3, 17856-0166-8, 17856-0166-7, 17856-0166-6, 17856-0166-5
- Manufacturer
- ATLANTIC BIOLOGICALS CORP | UNIT DOSE SOLUTIONS
- Effective date
- 2023-03-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP | UNIT DOSE SOLUTIONS | 2023-03-13 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0166-1 | ACETAMINOPHEN | 72 in 1 BOX, UNIT-DOSE | ELIXIR | 72 | 2 | |
| 17856-0166-2 | ACETAMINOPHEN | 10.15 mL in 1 CUP, UNIT-DOSE | ELIXIR | 10.15 | 2 | |
| 17856-0166-3 | ACETAMINOPHEN | 50 in 1 BOX, UNIT-DOSE | ELIXIR | 50 | 2 | |
| 17856-0166-4 | ACETAMINOPHEN | 20.31 mL in 1 CUP, UNIT-DOSE | ELIXIR | 20.31 | 2 | |
| 17856-0166-5 | ACETAMINOPHEN | 72 in 1 BOX, UNIT-DOSE | ELIXIR | 72 | 2 | |
| 17856-0166-6 | ACETAMINOPHEN | 15 mL in 1 CUP, UNIT-DOSE | ELIXIR | 15 | 2 | |
| 17856-0166-7 | ACETAMINOPHEN | 50 in 1 BOX, UNIT-DOSE | ELIXIR | 50 | 2 | |
| 17856-0166-8 | ACETAMINOPHEN | 31.2 mL in 1 CUP, UNIT-DOSE | ELIXIR | 31.2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0166 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP] | 2 | Legacy NDC, 8 package rows | 20230314_57b9b32c-6a5c-49d7-b4df-e0489a98168c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0166-1 | ML - Milliliter | 17856-0166 | 9225ee42-5e40-417c-8084-dfcad7bff924 | 1 | 2023-06-06 |
| 17856-0166-3 | ML - Milliliter | 17856-0166 | be1d41bb-feef-4f75-ae3e-15c3a339c1eb | 1 | 2023-06-06 |
| 17856-0166-5 | ML - Milliliter | 17856-0166 | 067cab20-451e-4e77-a8da-8838f258b66b | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walmart Inc. | 1557bd9b-3e7c-4769-e063-6394a90a9d91 | 2025-11-04 | Warnings | 362O9ITL9D |
| QUALITY CHOICE Maximum Strength Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | Chain Drug Marketing Association, Inc. | 40413cdb-68ac-70e1-e063-6394a90a9217 | 2025-11-04 | Warnings | 362O9ITL9D |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e618bc7-0f51-e586-e063-6294a90afe37 | 2025-11-03 | Warnings | 362O9ITL9D |
| Head Congestion plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e61b5b3-ad15-01bf-e063-6394a90a6ec3 | 2025-11-03 | Warnings | 362O9ITL9D |
| Cold plus Head Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 409540c0-1bab-9969-e063-6394a90a47c1 | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e60b340-bd60-9318-e063-6294a90ad079 | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus Pressure and Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e60e32f-3e5f-b775-e063-6294a90a097d | 2025-11-03 | Warnings | 362O9ITL9D |
| Sinus and Headache | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | HYVEE INC | 3e614265-b35a-5d01-e063-6294a90aad85 | 2025-11-03 | Warnings | 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 3e50b3f6-1e1a-41b9-e063-6394a90abe36 | 2025-11-03 | Warnings | 362O9ITL9D |
| Good Sense Pain Relief | ACETAMINOPHEN | L. Perrigo Company | 447de441-7d28-4415-81c5-4fc05622dd05 | 2025-11-03 | Warnings | 362O9ITL9D |
| Children Acetaminophen Oral Solution | ACETAMINOPHEN | VERITYRX. LLC | 42a17f54-7851-84fb-e063-6394a90a9ec1 | 2025-11-02 | Warnings | 307675 362O9ITL9D |
| M-PAP | ACETAMINOPHEN | VERITYRX, LLC | 42a1a128-a2dd-bbc9-e063-6294a90a4fe1 | 2025-11-02 | Warnings | 307675 362O9ITL9D |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Severe Sinus Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE | Shield Pharmaceuticals Corp | c296efd0-5030-4a26-a9b0-e66423d995dc | 2025-10-31 | Warnings | 362O9ITL9D |
| PhysiciansCare Non Aspirin Extra Strength | ACETAMINOPHEN | Acme United Corporation | c7006775-bd5b-412f-963d-ce5a158216c5 | 2025-10-31 | Warnings | 362O9ITL9D |
| Daytime Cold and Flu Max Maximum Strength Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Topco Associates, LLC | f7ebe482-cb22-4517-8463-3432cf60071d | 2025-10-31 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu Max Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Topco Associates, LLC | 787bff76-0ee2-4e7e-b908-876e4a3e3bfc | 2025-10-31 | Warnings | 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | Walgreens | f7aa624b-b00c-4fd3-9965-8e4d2b3eb4ba | 2025-10-31 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.